Side Effects of Chloroquine and Hydroxychloroquine on Skeletal Muscle: a Narrative Review
Open Access
- 31 October 2020
- journal article
- review article
- Published by Springer Nature in Current Pharmacology Reports
- Vol. 6 (6) , 364-372
Abstract
Purpose of Review Concerning adverse neuromuscular effects, there are quite a few reports about the incidence and prevalence of chloroquine (CQ) and hydroxychloroquine (HCQ) myopathy. Given the above, I decided to explore the relationships of these drugs with skeletal muscle in an attempt to clarify how they affect the muscle now and in the future, as millions of people are using CQ and HCQ. Recent Findings The literature review identified 28 publications about CQ/HCQ myopathy, totaling 56 patients, from 1963 to 2020. A compilation of all patients was carried out by computing demographic features, clinical aspects, laboratory exams, and clinical evolution. All articles but two represented a large series about incidence and prevalence of the myopathy. Fifty-nine percent used QC, mean daily dose was 393 mg per day, and mean duration of treatment was 37 months. The predominant underlying diseases were rheumatoid arthritis (42.8%) and lupus erythematosus (26.8%). Respiratory distress was present in 12.5% in patients with proximal muscle weakness (87.2%). Dysphagia and cervical and axial weakness were observed in a smaller percentage. Creatine kinase was elevated in 60.7%, and EMG showed a myopathic pattern in 54%. Muscle biopsy showed a vacuolar pattern in 53.7%, and curvilinear bodies (CB) were the predominant ultrastructural finding (86.8%). After drug withdrawal, 85.4% of patients improved, and 12.7% died from other causes than myopathy. Summary CQ and HCQ myopathy has been known for a long time, but the incidence is low, being described only with long-term use. The use of these drugs for a short period has not been reported, although a prolonged elimination half-life of these drugs actually exists.Keywords
This publication has 55 references indexed in Scilit:
- Hydroxychloroquine-Induced MyopathyJCR: Journal of Clinical Rheumatology, 2010
- Hydroxychloroquine and Colchicine Induced MyopathyThe Journal of Rheumatology, 2009
- Antimalarial myopathy: an underdiagnosed complication? Prospective longitudinal study of 119 patientsAnnals of the Rheumatic Diseases, 2006
- Rhabdomyolysis associated with acute renal failure in patients with severe acute respiratory syndromeInternational Journal Of Clinical Practice, 2005
- INCIDENCE OF MYOPATHY IN PATIENTS TREATED WITH ANTIMALARIALS. A REPORT OF THREE CASES AND A REVIEW OF THE LITERATURERheumatology, 1995
- Chloroquine-Induced NeuromyopathyDermatology, 1985
- Inhibition of lysosomal function in red and white skeletal muscles by chloroquineExperimental Neurology, 1981
- CHLOROQUINE-INDUCED MYOPATHYBritish Journal of Dermatology, 1969
- CHLOROQUINE NEUROMYOPATHYRheumatology, 1968
- Chloroquine neuromyopathy associated with keratopathy and retinopathy.BMJ, 1967